Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mallinckrodt Plc (NYSE:MNK)

56.23
Delayed Data
As of 4:01pm ET
 +2.18 / +4.03%
Today’s Change
50.90
Today|||52-Week Range
127.00
-24.65%
Year-to-Date
Trending Tickers: UAL, MNK, ENDP, BWA
Jun 21 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close54.05
Today’s open54.65
Day’s range54.65 - 56.69
Volume1,076,544
Average volume (3 months)2,506,218
Market cap$5.9B
Dividend yield--
Data as of 4:01pm ET, 06/28/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+12.30%
Earnings growth (next 5 years)+9.75%
Revenue growth (last year)+31.75%
P/E ratio17.1
Price/Sales2.40
Price/Book1.18

Competitors

 Today’s
change
Today’s
% change
TAROTaro Pharmaceutical ...+3.26+2.37%
ALKSAlkermes Plc+2.59+6.47%
VRXValeant Pharmaceutic...+1.27+6.78%
SGENSeattle Genetics Inc+2.40+6.60%
Data as of 4:02pm ET, 06/28/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)$2.00
Annual revenue (last year)$3.3B
Annual profit (last year)$322.1M
Net profit margin9.13%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Mark C. Trudeau
Senior Vice President-
Global Operations
Frank Scholz
Corporate headquarters
Chesterfield, Derbyshire

Forecasts

Partner Offers

Search for Jobs